Clinical experience and microbiologic characteristics of invasive Staphylococcus lugdunensis infection in a tertiary center in northern Taiwan

Journal of Microbiology, Immunology and Infection

Volumn 48, Issue 4, 2015, Pages 406-412

  Lin, Jung Fu ^a   Cheng, Chun Wen ^a   Kuo, An Jing ^b   Liu, Tsui Ping ^b   Yang, Chien Chang ^a   Huang, Ching Tai ^a   Lee, Ming Hsun ^a   Lu, Jang Jih ^a,b  

^a CHANG GUNG UNIVERSITY COLLEGE OF MEDICINE   (Taiwan)

^b CHANG GUNG UNIVERSITY   (Taiwan)

Author keywords

Bacteremia; Endocarditis; SCCmec type; Staphylococcus lugdunensis

Indexed keywords

CLINDAMYCIN; COTRIMOXAZOLE; ERYTHROMYCIN; OXACILLIN; PENICILLIN DERIVATIVE; TEICOPLANIN; VANCOMYCIN;

ADULT; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTEREMIA; BACTERIUM ISOLATE; CATHETER; CATHETER INFECTION; CLINICAL ARTICLE; FEMALE; GRAFT INFECTION; HUMAN; MALE; MICROBIOLOGY; MIDDLE AGED; MORTALITY; RETROSPECTIVE STUDY; RISK FACTOR; STAPHYLOCOCCUS INFECTION; STAPHYLOCOCCUS LUGDUNENSIS; TAIWAN; TERTIARY CARE CENTER; AGED; ASCITES; BACTERIAL GENE; GENE LOCUS; INCIDENCE; ISOLATION AND PURIFICATION; MICROBIAL SENSITIVITY TEST; PATHOLOGY; PENICILLIN RESISTANCE; PLEURA EFFUSION; STAPHYLOCOCCAL INFECTIONS; SURVIVAL ANALYSIS; SYNOVIAL FLUID; VERY ELDERLY;

ADULT; AGED; AGED, 80 AND OVER; ASCITES; BACTEREMIA; FEMALE; GENES, BACTERIAL; GENETIC LOCI; HUMANS; INCIDENCE; MALE; METHICILLIN RESISTANCE; MICROBIAL SENSITIVITY TESTS; MIDDLE AGED; PLEURAL EFFUSION; RETROSPECTIVE STUDIES; RISK FACTORS; STAPHYLOCOCCAL INFECTIONS; STAPHYLOCOCCUS LUGDUNENSIS; SURVIVAL ANALYSIS; SYNOVIAL FLUID; TAIWAN; TERTIARY CARE CENTERS;

EID: 84938289536     PISSN: 16841182     EISSN: 19959133     Source Type: Journal    
DOI: 10.1016/j.jmii.2013.12.010     Document Type: Article

References (40)

1. Freney J., Brun Y., Bes M., Meugnier H., Grimont F., Grimont P.A.D., et al. Staphylococcus lugdunensis sp. nov. and Staphylococcus schleiferi sp. nov., two species from human clinical specimens. Int J Syst Bacteriol 1988, 38:168-172.
2. Frank K.L., Del Pozo J.L., Patel R. From clinical microbiology to infection pathogenesis: how daring to be different works for Staphylococcus lugdunensis. Clin Microbiol Rev 2008, 21:111-133.
3. Kleiner E., Monk A.B., Archer G.L., Forbes B.A. Clinical significance of Staphylococcus lugdunensis isolated from routine cultures. Clin Infect Dis 2010, 51:801-803.
4. Wu A.B., Wang M.C., Tseng C.C., Lin W.H., Teng C.H., Huang A.H., et al. Clinical and microbiological characteristics of community-acquired Staphylococcus lugdunensis infections in Southern Taiwan. J Clin Microbiol 2011, 49:3015-3018.
5. Liu P.Y., Huang Y.F., Tang C.W., Chen Y.Y., Hsieh K.S., Ger L.P., et al. Staphylococcus lugdunensis infective endocarditis: a literature review and analysis of risk factors. J Microbiol Immunol Infect 2010, 43:478-484.
6. Zinkernagel A.S., Zinkernagel M.S., Elzi M.V., Genoni M., Gubler J., Zbinden R., et al. Significance of Staphylococcus lugdunensis bacteremia: report of 28 cases and review of the literature. Infection 2008, 36:314-321.
7. Patel R., Piper K.E., Rouse M.S., Uhl J.R., Cockerill F.R., Steckelberg J.M. Frequency of isolation of Staphylococcus lugdunensis among staphylococcal isolates causing endocarditis-a 20-year experience. J Clin Microbiol 2000, 38:4262-4263.
8. Molina J., Penuela I., Lepe J.A., Gutierrez-Pizarraya A., Gomez M.J., Garcia-Cabrera E., et al. Mortality and hospital stay related to coagulase-negative Staphylococci bacteremia in non-critical patients. J Infect 2013, 66:155-162.
9. Fernández-Rufete A., García-Vázquez E., Hernández-Torres A., Canteras M., Ruiz J., Gómez J. Coagulase-negative Staphylococcus bacteremia: prognosis factors and influence of antibiotic treatment. Rev Esp Quimioter 2012, 25:199-205.
10. Pfaller M.A., Jones R.N., Doern G.V., Sader H.S., Kugler K.C., Beach M.L. Survey of blood stream infections attributable to gram-positive cocci: frequency of occurrence and antimicrobial susceptibility of isolates collected in 1997 in the United States, Canada, and Latin America from the SENTRY Antimicrobial Surveillance Program. Diagn Microbiol Infect Dis 1999, 33:283-297.
11. Choi S.H., Chung J.W., Lee E.J., Kim T.H., Lee M.S., Kang J.M., et al. Incidence, characteristics, and outcomes of Staphylococcus lugdunensis bacteremia. J Clin Microbiol 2010, 48:3346-3349.
12. Shin J.H., Jung H.J., Lee H.R., Kim J.H., Kim H.R., Lee J.N. Prevalence, identification, and antimicrobial susceptibility of Staphylococcus lugdunensis from various clinical specimens in Korea. Jpn J Infect Dis 2007, 60:312-313.
13. Chung K.P., Chang H.T., Liao C.H., Chu F.Y., Hsueh P.R. Staphylococcus lugdunensis endocarditis with isolated tricuspid valve involvement. J Microbiol Immunol Infect 2012, 45:248-250.
14. Koksal F., Yasar H., Samasti M. Antibiotic resistance patterns of coagulase-negative staphylococcus strains isolated from blood cultures of septicemic patients in Turkey. Microbiol Res 2009, 164:404-410.
15. Tsao Y.T., Wang W.J., Lee S.W., Hsu J.C., Ho F.M., Chen W.L. Characterization of Staphylococcus lugdunensis endocarditis in patients with cardiac implantable electronic devices. Int J Infect Dis 2012, 16:e464-e467.
16. Pereira E.M., Schuenck R.P., Nouér S.A., Santos K.R. Methicillin-resistant Staphylococcus lugdunensis carrying SCCmec type V misidentified as MRSA. Braz J Infect Dis 2011, 15:293-295.
17. Tee W.S., Soh S.Y., Lin R., Loo L.H. Staphylococcus lugdunensis carrying the mecA gene causes catheter-associated bloodstream infection in premature neonate. J Clin Microbiol 2003, 41:519-520.
18. Naimi T.S., LeDell K.H., Como-Sabetti K., Borchardt S.M., Boxrud D.J., Etienne J., et al. Comparison of community- and health care-associated methicillin-resistant Staphylococcus aureus infection. JAMA 2003, 290:2976-2984.
19. Souvenir D., Anderson D.E., Palpant S., Mroch H., Askin S., Anderson J., et al. Blood cultures positive for coagulase-negative staphylococci: antisepsis, pseudobacteremia, and therapy of patients. J Clin Microbiol 1998, 36:1923-1926.
20. Dellinger R.P., Levy M.M., Rhodes A., Annane D., Gerlach H., Opal S.M., et al. Surviving sepsis campaign: international guidelines for management of severe sepsis and septic shock: 2012. Intensive Care Med 2013, 39:165-228.
21. Kidney Disease: improving Global Outcomes (KDIGO) Acute Kidney Injury Work Group. KDIGO clinical practice guideline for acute kidney injury. Kidney Int 2012, 2:1-138.
22. Li J.S., Sexton D.J., Mick N., Nettles R., Fowler V.G., Ryan T., et al. Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis. Clin Infect Dis 2002, 30:633-638.
23. Bannerman T.L., Peacock S.J. Staphylococcus, Micrococcus, and other catalase-positive cocci. Manual of clinical microbiology 2007, 390-411. American Society of Microbiology, Washington, DC. 9th ed. P.R. Murray, E.J. Baron, J.H. Jorgensen, M.A. Pfaller, R.H. Yolken (Eds.).
24. Noguchi N., Goto K., Ro T., Narui K., Ko M., Nasu Y., et al. Using the tannase gene to rapidly and simply identify Staphylococcus lugdunensis. Diagn Microbiol Infect Dis 2010, 66:120-123.
25. Szabados F., Woloszyn J., Richter C., Kaase M., Gatermann S. Identification of molecularly defined Staphylococcus aureus strains using matrix-assisted laser desorption/ionization time of flight mass spectrometry and the Biotyper 2.0 database. J Med Microbiol 2010, 59:787-790.
26. Performance standards for antimicrobial susceptibility testing; twenty-second informational supplement 2012, Clinical and Laboratory Standards Institute, CLSI, Wayne, PA, CLSI document M100-MS22.
27. Kondo Y., Ito T., Ma X.X., Watanabe S., Kreiswirth B.N., Etienne J., et al. Combination of multiplex PCRs for staphylococcal cassette chromosome mec type assignment: rapid identification system for mec, ccr, and major differences in junkyard regions. Antimicrob Agents Chemother 2007, 51:264-274.
28. Fadel H.J., Patel R., Vetter E.A., Baddour L.M. Clinical significance of a single Staphylococcus lugdunensis-positive blood culture. J Clin Microbiol 2011, 49:1697-1699.
29. Carbonnelle E., Beretti J.L., Cottyn S., Quesne G., Berhe P., Nassif X., et al. Rapid identification of staphylococci isolated in clinical microbiology laboratories by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol 2007, 45:2156-2161.
30. Fox K., Fox A., Rose J., Walla M. Speciation of coagulase negative staphylococci, isolated from indoor air, using SDS PAGE gel bands of expressed proteins followed by MALDI TOF MS and MALDI TOF-TOF MS-MS analysis of tryptic peptides. J Microbiol Methods 2011, 84:243-250.
31. Bobin S., Durand-Dubief A., Bouhour D., Kirkorian G., Vandenesch F., Etienne J., et al. Pacemaker endocarditis due to Staphylococcus lugdunensis: report of two cases. Clin Infect Dis 1999, 28:404-405.
32. Nilsson M., Bjerketorp J., Wiebensjö A., Ljungh A., Frykberg L., Guss B. A von Willebrand factor-binding protein from Staphylococcus lugdunensis. FEMS Microbiol Lett 2004, 234:155-161.
33. Mitchell J., Tristan A., Foster T.J. Characterization of the fibrinogen-binding surface protein Fbl of Staphylococcus lugdunensis. Microbiology 2004, 150:3831-3841.
34. Marchocki Z., Collins K., Lehane E., Reilly P.O., O'Donoghue K. Staphylococcus lugdunensis cultured from the amniotic fluid at caesarean section. PLoS One 2013, 8:e56373.
35. Ebright J.R., Penugonda N., Brown W. Clinical experience with Staphylococcus lugdunensis bacteremia: a retrospective analysis. Diagn Microbiol Infect Dis 2004, 48:17-21.
36. Hellbacher C., Törnqvist E., Söderquist B. Staphylococcus lugdunensis: clinical spectrum, antibiotic susceptibility, and phenotypic and genotypic patterns of 39 isolates. Clin Microbiol Infect 2006, 12:43-49.
37. Performance standards for antimicrobial susceptibility testing; twelfth informational supplement 2002, Clinical and Laboratory Standards Institute, CLSI, Wayne, PA, CLSI document M100-S12.
38. Babu E., Oropello J. Staphylococcus lugdunensis: the coagulase-negative staphylococcus you don't want to ignore. Expert Rev Anti Infect Ther 2011, 9:901-907.
39. Clinical and Laboratory Standards Institute Performance standards for antimicrobial susceptibility testing; Fifteenth informational supplement 2005, CLSI, Wayne, PA, CLSI document M100--S15.
40. Chuang Y.Y., Huang Y.C. Molecular epidemiology of community-associated meticillin-resistant Staphylococcus aureus in Asia. Lancet Infect Dis 2013, 13:698-708.